期刊文献+

耐亚胺培南铜绿假单胞菌致医院感染危险因素的病例对照研究 被引量:17

A case-control study on the risk factors of nosocomial infection caused by imipenem-resistant Pseudomonas aeruginosa
原文传递
导出
摘要 目的探讨耐亚胺培南铜绿假单胞菌(IRPA)导致医院感染的危险因素.方法选取2002年1月至2003年12月收治的67例IRPA医院感染病例、150例亚胺培南敏感铜绿假单胞菌(ISPA)医院感染者为病例组,同时选取同一病区,接受相似治疗措施的非铜绿假单胞菌感染的住院患者为对照组,其中敏感对照组159例,耐药对照组200例.分别对两组患者的危险因素进行病例对照研究,采用非条件logistic回归分析法进行分析.结果多因素非条件logistic回归分析表明,IRPA医院感染的发生与住院时间长短(OR=1.03,95% CI:1.01~1.04)、亚胺培南(OR=4.65,95%CI:1.35~11.52)、哌拉西林/他唑巴坦(OR=3.37,95% CI:1.85~9.43)及喹诺酮类抗菌药物(OR=1.85,95% CI:1.25~5.34)的使用有关;而ISPA医院感染与三代头孢(OR=2.54,95% CI:1.26~5.23)及氨基糖苷类抗生素(OR=1.86,95% CI:1.42~3.26)的使用、住院时间长短(OR=1.05,95% CI:1.03~1.05)有关.结论为减少IRPA医院感染的发生,在限制使用亚胺培南的同时,应尽可能根据药物敏感试验的结果,合理使用其他抗菌药物. Objective To explore the risk factors for nosocomial infection caused by imipenem-resistant Pseudomonas aeruginosa (IRPA). Methods A case-control study was carried out for the comparison of 2 groups of ‘case’ patients with ‘controlled’ patients. The first group of ‘case’ patients had nosocomial isolation of IRPA, and the second group had imipenem-susceptible Pseudomonas aeruginosa (ISPA). ‘Control’ patients were selected from the same medical or surgical services from which ‘case’ patients were receiving care when isolation of IRPA or ISPA occurred. Risk factors analyzed included the use of antimicrobials, comorbid conditions, and demographic variables. IRPA was recovered from 67 patients, and ISPA from 150 patients while the control case were 200 and 159 respectively. All patients were from Renmin Hospital of Wuhan University during Jan 2002 to Dec 2003. Data were analyzed with unconditional logistic regression and principal component analysis. Results Data from multivariate unconditional logistic regression analysis showed that the independent risk factors for IRPA nosocomial infection were: time at risk( OR = 1.03 ,95% CI : 1.01- 1.04 ),imipenem( OR = 4.65 ,95% CI : 1.35- 11.52 ),PIP/TAZ( OR = 3.37 , 95% CI : 1.85- 9.43 ) and quinolones( OR = 1.85 ,95% CI : 1.25- 5.34 ) while the third cephalosporins( OR =2.54,95% CI : 1.26- 5.23 ) and aminoglycoside antibiotics( OR = 1.86 ,95% CI : 1.42- 3.26 ),time at risk( OR = 1.05 ,95% CI : 1.03- 1.05 ) were associated with isolated ISPA. Conclusion Nosocomial infection of IRPA could be caused by the use of imipenem and other antibiotics, suggesting that to limit the use of imipenem was not sufficient to contain the increasing incidence of IRPA.
出处 《中华流行病学杂志》 CAS CSCD 北大核心 2005年第7期511-514,共4页 Chinese Journal of Epidemiology
基金 湖北省卫生厅重点项目资助(WJ01564)
  • 相关文献

参考文献7

  • 1Skarlowsky JA, Draghi DC, Jones ME, et al. Urveillance for antimicrobial susceptibility among clinical isolates of Pseudomonas aeruginosa and Acinetobacter baumannii from hospitalized patients in the United States, 1998 to 2001. Antimicrob Agents Chemother,2003.47:1681-1688.
  • 2申正义,孙自镛,王洪波.湖北地区临床细菌耐药性监测[J].中华医院感染学杂志,2002,12(2):91-93. 被引量:64
  • 3医院感染诊断标准(试行)[J].中华医学杂志,2001,81(5):314-320. 被引量:5928
  • 4Harris AD, Karchmer TB, Carmeli Y, et al. Methodological principle case-control studies that analysed risk factors for antibiotic resistance:a systematic review. Clin Infect Dis,2001,32:1055-1061.
  • 5Harris AD, Smith D, Johnson JA, et al. Risk factor of imipenemresistant Pseudomonas aeruginosa among hospitalized patients. Clin Infect Dis, 2002,34: 340-345.
  • 6Livermore DM. Multiple mechanism of antimicrobial resistance in Pseudomonas aeruginosa: our worst nightmare? Antimicrobial Resistance, 2002, 34: 634 -640.
  • 7Olson B, Weistein RA, Nathan C, et al. Epidemiology of endemic Pseudomonas aeruginosa: why infection control efferts have failed. J Infect Dis, 1984,150: 808-816.

二级参考文献7

  • 1National Committee for Clinical Laboratory Standards.Performance Standards for Antimicrobial Susceptibility Testing;Ninth Informational Supplement,NCCLS documents M100-S9[S].Pennsylvania:NCCLS,1999.1-103.
  • 2Levy S.Multidrug resistance-a sign of the times[J].N Engl J Med,1998,338:1376-1378.
  • 3Witte W.Antibiotic resistance in Gram-positive bacteria:epidemiological aspects[J].J Antimicrob Chemother,1999,44Topic A:1-9.
  • 4Andrews J,Ashby J,Jevons G,et al.Antimicrobial resistance in Gram-positive pathogens isolated in the UK between October 1996 and January 1997[J].J Antimicrob Chemother,1999,43:689-698.
  • 5Schmitz FJ,Verhoef J,Fluif AC,et al.Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY Surveillance Propramme[J].J Antimicrob Chemother,1999,41:783-792.
  • 6申正义,孙自镛,王洪波.武汉地区临床分离菌耐药性监测[J].中华内科杂志,1998,37(7):440-443. 被引量:42
  • 7汪复,吴溰,朱德妹.1998年上海地区细菌耐药性监测[J].中华内科杂志,1999,38(11):729-732. 被引量:133

共引文献5990

同被引文献133

引证文献17

二级引证文献154

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部